Charissa Lee, OD Named Director, Education, Johnson & Johnson Vision Care, North America

By


JACKSONVILLE, Fla.—Johnson & Johnson Vision Care, Inc., announced the appointment of Charissa Lee, OD to the role of director, education, Johnson & Johnson Vision Care, Inc., North America (JJVCI). In this role, Dr. Lee will lead the development of programs supporting the schools and colleges of optometry across the U.S. She will report directly to Millicent Knight, OD, head of professional affairs, JJVCI.

“Johnson & Johnson Vision Care is committed to supporting the education of the next generation of optometrists,” said Dr. Knight. “With the addition of Dr. Lee to our Professional Affairs team, we look forward to working even more closely with optometry schools to provide students with additional tools and resources they need to become effective, successful practitioners.”

A graduate of State University of New York, State College of Optometry Dr. Lee brings over 12 years of hospital-based and private practice optometry experience to her new position, including providing patient care in diverse settings ranging from a Veteran Administration hospital to a tertiary eyecare clinic in the city of Hangzhou in eastern China. In 2007, she opened her own private practice in Irvine, Calif.

Prior to joining JJVC, Dr. Lee served as a professional affairs consultant to the company, where she regularly educated optometric practitioners on clinical issues and practice management strategies across the country. Since 2012, she has served as program director and lecturer for educational events at The Vision Care Institute, LLC.

Dr. Lee is a member of the California Optometric Association, the American Optometric Association, and the Asian American Optometric Society, where she served as an active board member for five years. She has been involved with humanitarian eyecare missions, as part of the Northeast Chapter of Volunteers Optometric Services to Humanity, to impoverished countries and is continually involved with the Susan G. Komen Foundation.